The presentation will take place during Parallel Session #5 on Tuesday 26th January, and following this, Bertrand will also discuss the pathogenic
E. coli O157:H7 assay (characterized by the presence of the stx and eae genes, as described in the EFSA publication) together with a demonstration of
Listeria identification performed in minutes.
Several industries, including food safety, have already adopted qPCR as a rapid method for detecting microorganisms. Microbiological quality control testing in the biopharmaceutical industry includes several applications well-suited to qPCR but these requirements have not been served well by previous qPCR platforms. Pall's GeneDisc technology is changing this by providing a unique, highly simplified and controlled method well suited to these requirements. Bertrand will also explain how the technology offers:
- Same-day data, minimizing the need to operate manufacturing processes at risk
- Organism-specific quantification of microbial contaminants, ensuring accurate and precise results
- Highly reproducible data based on a novel 'consumable and instrument' design
- Minimal operator-attended steps, thus minimizing errors and maximizing ease of use and consistency
Also, take time to visit Pall's exhibition booth where the GeneDisc® technology will be on display, with Pall experts also available to assist you with questions and queries related to qPCR.
